Education
About Us
Working with TipRanks
Follow Us
Lyka Labs Limited (IN:LYKALABS)
:LYKALABS
LYKALABS Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹90.20 - ₹175.95
Previous CloseN/A
Volume78.41K
Average Volume (3M)3.30K
Market Cap
₹3.92B
Enterprise Value₹4.38B
Total Cash (Recent Filing)₹13.63M
Total Debt (Recent Filing)₹391.84M
Price to Earnings (P/E)49.9
Beta0.93
Next Earnings
Aug 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.50
Shares Outstanding35,690,000
10 Day Avg. Volume1,009
30 Day Avg. Volume3,300
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)3.91
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lyka Labs Limited News
PremiumCompany Announcements
Lyka Labs Promoters Declare No Share EncumbranceLYKALABS FAQ
What was Lyka Labs Limited’s price range in the past 12 months?
Lyka Labs Limited lowest stock price was ₹90.20 and its highest was ₹175.95 in the past 12 months.
What is Lyka Labs Limited’s market cap?
Lyka Labs Limited’s market cap is ₹3.92B.
When is Lyka Labs Limited’s upcoming earnings report date?
Lyka Labs Limited’s upcoming earnings report date is Aug 14, 2025 which is in 28 days.
How were Lyka Labs Limited’s earnings last quarter?
Lyka Labs Limited released its earnings results on May 26, 2025. The company reported ₹0.496 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.496.
Is Lyka Labs Limited overvalued?
According to Wall Street analysts Lyka Labs Limited’s price is currently Overvalued.
Does Lyka Labs Limited pay dividends?
Lyka Labs Limited does not currently pay dividends.
What is Lyka Labs Limited’s EPS estimate?
Lyka Labs Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lyka Labs Limited have?
Lyka Labs Limited has 35,690,000 shares outstanding.
What happened to Lyka Labs Limited’s price movement after its last earnings report?
Lyka Labs Limited reported an EPS of ₹0.496 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.043%.
Which hedge fund is a major shareholder of Lyka Labs Limited?
Currently, no hedge funds are holding shares in IN:LYKALABS
Company Description
Lyka Labs Limited
Lyka Labs Limited (LYKALABS) is a pharmaceutical company engaged in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company operates primarily in the healthcare sector, offering a diverse portfolio of generic medicines, active pharmaceutical ingredients (APIs), and specialty drugs. With a focus on quality and innovation, Lyka Labs aims to address various therapeutic areas, including dermatology, cardiology, and neurology.
Technical Analysis
Brooks Laboratories Limited
―
Medico Remedies Ltd.
―
Nureca Ltd.
―
SMS Lifesciences India Ltd.
―
Zim Laboratories Ltd.
―